MASTERY
Live / Registered — Registered (as of 03 Oct 2023)
What this means for you
Registered since 03 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88778608
- Registration number
- 7183213
- Mark type
- Stylized text
- Filed
- 30 Jan 2020
- Published for opposition
- 02 Jun 2020
- Registered
- 03 Oct 2023
- Attorney of record
- Susan Neuberger Weller
Goods and services
- Class 042 — Scientific and technological services: conducting clinical trials for others in the field of pharmaceuticals for the treatment of attention deficit hyperactivity disorder (ADHD)
Owner
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
- Cingulate Therapeutics LLC, Kansas City, KS, US
Prosecution history
- 03 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 29 Aug 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Aug 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Jul 2023 — USE AMENDMENT FILED
- 27 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 10 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Feb 2023 — SOU EXTENSION 5 GRANTED
- 24 Jan 2023 — SOU EXTENSION 5 FILED
- 09 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Jan 2023 — ASSIGNED TO EXAMINER
- 19 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2022 — SOU EXTENSION 4 GRANTED